IE 11 is not supported. For an optimal experience visit our site on another browser.

InoLife Technologies, Inc. to Release Commercial Spots for DNA-Based Products

RALEIGH, N.C., May 20, 2011 (GLOBE NEWSWIRE) -- InoLife Technologies, Inc. (OTCBB:INOL), a service-based healthcare products development, integration and marketing company, has announced that it will release three additional commercial spots highlighting the company's DNA-based products.
/ Source: GlobeNewswire

RALEIGH, N.C., May 20, 2011 (GLOBE NEWSWIRE) -- InoLife Technologies, Inc. (OTCBB:INOL), a service-based healthcare products development, integration and marketing company, has announced that it will release three additional commercial spots highlighting the company's DNA-based products.

Recently, InoLife appointed Wayne Wiggins as Vice President of Advertising. Mr. Wiggins is responsible for developing the commercials through his own production company, Wideshot Productions. The commercials and overall advertising are key components to InoLife's goal to achieve mass sales and brand recognition for its consumer-based DNA testing products.

InoLife's DNA-based products provide individuals with meaningful information about ancestry, genetic makeup, and potential predisposition to certain diseases.

"Showcasing our products in this format is part of InoLife's initiative to reach a broader consumer audience. This follows on the heels of our recent announcement that we plan to support each of our DNA-based product lines across all social media sites," said Gary Berthold, President and CEO of InoLife. 

"Wayne has more than 30 years of experience in the film and television industry, and he's the winner of two Emmy Awards, so we are confident in his ability that the finished product will be of the highest quality with maximum results," said Berthold.

Two of the three commercial spots will be available in the next several weeks and ready for distribution via social media networks by next month.

About InoLife Technologies, Inc.

InoLife Technologies, Inc. is a leader in the development and marketing of state-of-the-art DNA Testing products within the US. The Company's mission is to aggressively identify, develop and deliver innovative and affordable healthcare products and services directly to the marketplace. By targeting cutting-edge DNA-based testing and reporting methodologies, the Company is able to significantly benefit the health and wellness needs of both individuals and their healthcare providers. 

InoLife Technologies, Inc. has developed a range of products that will be sold directly to consumers through e-commerce, direct sales, pharmacies, retailers, distributors and healthcare providers. It also offers products that are sold only to physicians, hospitals, outpatient facilities and others in the medical community for use with their patients.

About Wideshot Productions

Wideshot Productions was founded and is headed by Wayne Wiggins, winner of two national Emmy Awards as well as numerous awards for the projects Wayne has produced and directed. As a member of the Writer's Guild, Wayne has written, produced, and directed a very wide range of projects in both videotape and film, including some of the earliest and most highly recognized infomercials ( The "Ginzu Knife" by Popiel), and most recently the "Proactiv" infomercial for Guthy- Renker. He's also done 30 and 60 commercial second spots, film documentaries, video news releases, training and instructional videotapes, editorials and infotainment television segments, television news reports, television advertising campaigns, and much more.

Forward-Looking Statements

Safe Harbor Statement under the Private securities Litigation Reform Act of 1995: The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements including, but not limited to, certain delays beyond the Company's control with respect to market acceptance of new technologies, products and services, delays in testing and evaluation of products and services, and other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission.

CONTACT: INVESTOR RELATIONS: Steve Reiss BUZZBAHN, LLC 516-570-3850 inol@buzzbahnllc.com www.buzzbahnllc.com PUBLIC RELATIONS: Rhonda Lipschutz rlipschutz@inolifetech.com